20 year's experience has generated strong scientific support for interchangeability of biosimilars approved according to standards set by major regulatory authorities such as #FDA and #ema. This statement from US-FDA is fully aligned with our statement from April 2023 (https://lnkd.in/d9Fkqmk5) underpinning that biosimilars offers an alternative that are equally safe and effective as their reference counterparts
CDER’s recent research takes the Spotlight! 🌟 Check out the latest Spotlight on CDER Science, which highlights research that examined the safety aspects of switching between reference #biologics and #biosimilars: https://lnkd.in/d2s2EtHU